miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4.
Wu, Yaxun
miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4. [electronic resource] - Pathology, research and practice Nov 2019 - 152603 p. digital
Publication Type: Journal Article
1618-0631
10.1016/j.prp.2019.152603 doi
Apoptosis Regulatory Proteins--biosynthesis
Cell Adhesion--drug effects
Cell Line, Tumor
Drug Resistance, Neoplasm--genetics
Gene Expression Regulation, Neoplastic--genetics
Humans
MicroRNAs--genetics
Multiple Myeloma--genetics
Proto-Oncogene Proteins c-akt--biosynthesis
RNA-Binding Proteins--biosynthesis
miR-182 contributes to cell adhesion-mediated drug resistance in multiple myeloma via targeting PDCD4. [electronic resource] - Pathology, research and practice Nov 2019 - 152603 p. digital
Publication Type: Journal Article
1618-0631
10.1016/j.prp.2019.152603 doi
Apoptosis Regulatory Proteins--biosynthesis
Cell Adhesion--drug effects
Cell Line, Tumor
Drug Resistance, Neoplasm--genetics
Gene Expression Regulation, Neoplastic--genetics
Humans
MicroRNAs--genetics
Multiple Myeloma--genetics
Proto-Oncogene Proteins c-akt--biosynthesis
RNA-Binding Proteins--biosynthesis